![David Lowrance](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Lowrance
Finanzdirektor/CFO bei
SAVARA INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
David L.
Lowrance is Director at Life Science Washington since 2014.
Mr. Lowrance is CFO, Secretary & Chief Administrative Officer at Savara, Inc. since 2022.
Former roles include Head-Finance at BorgWarner, Inc., Senior Accountant at Ernst & Young LLP, Chief Financial Officer & Vice President at Cumberland Pharmaceuticals, Inc. from 2003 to 2011, Chief Financial Officer at Aravas, Inc., Chief Financial Officer & Treasurer at Edgemont Pharmaceuticals LLC from 2014 to 2016, Chief Financial Officer & Secretary at Acucela, Inc. from 2011 to 2014, and Chief Financial Officer at Kubota Pharmaceutical Holdings Co., Ltd. Education includes an undergraduate degree from the University of Georgia, conferred in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SAVARA, INC. 0.21% | 06.04.2026 | 436’032 ( 0.21% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von David Lowrance
| Unternehmen | Position | Beginn |
|---|---|---|
| SAVARA INC. | Finanzdirektor/CFO | 01.11.2016 |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Direktor/Vorstandsmitglied | 01.07.2014 |
Ehemalige bekannte Positionen von David Lowrance
| Unternehmen | Position | Ende |
|---|---|---|
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Finanzdirektor/CFO | 01.10.2016 |
| ACUCELA INC | Finanzdirektor/CFO | 19.09.2014 |
| CUMBERLAND PHARMACEUTICALS INC. | Finanzdirektor/CFO | 04.04.2011 |
Aravas, Inc.
 Aravas, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative drugs for the treatment of serious and life-threatening conditions | Finanzdirektor/CFO | - |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Finanzdirektor/CFO | - |
Ausbildung von David Lowrance
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
BorgWarner, Inc.
 BorgWarner, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures combustion, hybrid and electric technologies for light, medium and heavy duty vehicles | Producer Manufacturing |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Cumberland Pharmaceuticals, Inc.
 Cumberland Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acquires, develops and commercializes branded prescription products | Health Technology |
Aravas, Inc.
Aravas, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative drugs for the treatment of serious and life-threatening conditions | Health Technology |
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Kubota Pharmaceutical Holdings Co. Ltd.
 Kubota Pharmaceutical Holdings Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines and medical devices for eye diseases | Health Technology |
Savara, Inc.
 Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
